Since CD11b and CD66b were also found to be expressed on polymorphonuclear‐myeloid derived suppressive cells (PMN‐MDSC) which were described as a population of CD33+HLA‐DR− cells in the tumor microenvironment,[27] we then introduced more markers to distinguish these cells with PMN‐MDSC. The gene discussed is CD33; the disease is neoplasm.